<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="myotonia-c" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">myotonia-c</book-part-id>
      <title-group>
        <title>Myotonia Congenita</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dun&#x000f8;</surname>
            <given-names>Morten</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Molecular Genetic Laboratory<break/>Department of Clinical Genetics<break/>University Hospital Copenhagen<break/>Copenhagen, Denmark</aff>
          <email>mdunoe@rh.dk</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Colding-J&#x000f8;rgensen</surname>
            <given-names>Eskild</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Department of Neurology<break/>Roskilde Hospital<break/>University of Copenhagen<break/>Copenhagen, Denmark</aff>
          <email>esco@regionsjaelland.dk</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>3</day>
          <month>8</month>
          <year>2005</year>
        </date>
        <date date-type="updated">
          <day>6</day>
          <month>8</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="mstn" document-type="chapter">Myostatin-Related Muscle Hypertrophy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="myotonic-d" document-type="chapter">Myotonic Dystrophy Type 1</related-object>
      <abstract id="myotonia-c.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, facial muscles, and tongue may be involved. Stiffness is relieved by repeated contractions of the muscle (the &#x0201c;warm-up&#x0201d; phenomenon). Muscles are usually hypertrophic. The autosomal recessive form of myotonia congenita is often associated with more severe symptoms than the autosomal dominant form. Individuals with the autosomal recessive form may have progressive, minor distal weakness and attacks of transient weakness brought on by movement after rest. The age of onset is variable: in autosomal dominant myotonia congenita, onset of symptoms is usually in infancy or early childhood; in the autosomal recessive form, the average age of onset is slightly older. In both, onset may be as late as the third or fourth decade of life.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Myotonia congenita is diagnosed clinically by the presence of episodes of myotonia beginning in early childhood, alleviation of stiffness by brief exercise, myotonic contraction elicited by percussion of muscles, electromyography revealing myotonic bursts, elevated serum creatine kinase concentration, and family history consistent with autosomal dominant or autosomal recessive inheritance. <italic toggle="yes">CLCN1</italic>, encoding a chloride channel, is the only gene known to be associated with myotonia congenita. Sequence analysis of <italic toggle="yes">CLCN1</italic> detects more than 95% of pathogenic variants causing both the autosomal recessive and autosomal dominant forms of myotonia congenita.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Muscle stiffness may respond to sodium channel blockers such as mexiletine (currently the medication with best documented effect), carbamazepine, or phenytoin. Beneficial effects have also been reported with quinine, dantrolene, and acetazolamide.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Depolarizing muscle relaxants (e.g., suxamethonium), adrenaline, beta-adrenergic agonists, propranolol, and colchicine may aggravate myotonia.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Because individuals with myotonia congenita may be at increased risk for adverse anesthesia-related events, testing of at-risk individuals during childhood to clarify their genetic status is appropriate.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Myotonia congenita is inherited in either an autosomal recessive (Becker disease) or an autosomal dominant manner (Thomsen disease); the same pathogenic variant may occur in families with both types of inheritance. In the autosomal dominant form, the proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is unknown; each child of an individual with autosomal dominant myotonia congenita has a 50% chance of inheriting the pathogenic variant. In autosomal recessive myotonia congenita, heterozygotes are usually asymptomatic; at conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Establishing the mode of inheritance in a simplex case (i.e., a single occurrence in a family) may not be possible unless molecular genetic testing reveals two pathogenic variants in <italic toggle="yes">CLCN1</italic>, in which case inheritance can be assumed to be autosomal recessive. Testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible if the pathogenic variant(s) in the family are known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="myotonia-c.Diagnosis">
        <title>Diagnosis</title>
        <sec id="myotonia-c.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Myotonia congenita <bold>should be suspected</bold> in individuals with the following clinical and laboratory findings.</p>
          <p>
            <bold>Clinical findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Episodes of muscle stiffness (myotonia) or cramps beginning in early childhood (Myotonia is defined as impaired relaxation of skeletal muscle after voluntary contraction.)</p>
            </list-item>
            <list-item>
              <p>Alleviation of stiffness by brief exercise (known as the &#x0201c;warm-up effect&#x0201d;)</p>
            </list-item>
            <list-item>
              <p>Myotonic contraction elicited by percussion of muscles</p>
            </list-item>
            <list-item>
              <p>Family history consistent with either autosomal dominant or autosomal recessive inheritance</p>
            </list-item>
          </list>
          <p>
            <bold>Laboratory findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Serum creatine kinase concentration</bold> that may be slightly elevated (&#x02264;3-4x the upper limits of normal)</p>
            </list-item>
            <list-item>
              <p><bold>Electromyography (EMG)</bold> performed with needle electrodes that discloses characteristic showers of spontaneous electrical activity (myotonic bursts)</p>
            </list-item>
          </list>
          <p>Note: <named-content content-type="highlight-1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://onlinelibrary.wiley.com/doi/10.1002/ana.22238/pdf">Guidelines</ext-link></named-content> for molecular genetic testing based on electrophysiologic tests in myotonic disorders have been formulated [<xref ref-type="bibr" rid="myotonia-c.REF.tan.2011">Tan et al 2011</xref>]; however, in most cases the clinical features provide sufficient guidance.</p>
          <p><bold>Muscle biopsy</bold> is usually normal, although absence of type 2B fibers is sometimes noted. In very severe cases of autosomal recessive myotonia congenita, myopathic changes may be found.</p>
          <p>Note: Muscle biopsy is not required to consider or establish the diagnosis of myotonia congenita.</p>
        </sec>
        <sec id="myotonia-c.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of myotonia congenita <bold>is established</bold> in a proband with identification of a heterozygous pathogenic variant or biallelic pathogenic variants in <italic toggle="yes">CLCN1</italic> (see <xref ref-type="table" rid="myotonia-c.T.summary_of_molecular_geneti">Table 1</xref>).</p>
          <p>Note: Distinguishing between autosomal dominant and autosomal recessive myotonia congenita depends mainly on the family history (i.e., the presence of an affected parent), as some pathogenic variants can occur in both autosomal recessive myotonia congenita and autosomal dominant myotonia congenita.</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">CLCN1</italic> is performed first followed by gene-targeted deletion/duplication analysis if no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">CLCN1</italic> and other genes of interest (see <xref ref-type="sec" rid="myotonia-c.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and sensitivity of multi-gene panels vary by laboratory and over time.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, genome sequencing, and mitochondrial sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel) fails to confirm a diagnosis in an individual with features of myotonia congenita. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="myotonia-c.T.summary_of_molecular_geneti" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Myotonia Congenita</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_myotonia-c.T.summary_of_molecular_geneti_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_myotonia-c.T.summary_of_molecular_geneti_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_myotonia-c.T.summary_of_molecular_geneti_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_myotonia-c.T.summary_of_molecular_geneti_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">CLCN1</italic>
                  </td>
                  <td headers="hd_h_myotonia-c.T.summary_of_molecular_geneti_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_myotonia-c.T.summary_of_molecular_geneti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;95%</td>
                </tr>
                <tr>
                  <td headers="hd_h_myotonia-c.T.summary_of_molecular_geneti_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_myotonia-c.T.summary_of_molecular_geneti_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1%-5%&#x000a0;<sup>4</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="myotonia-c.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="myotonia-c" object-id="myotonia-c.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="myotonia-c.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="myotonia-c.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice-site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="myotonia-c.TF.1.3">
                <label>3. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic <italic toggle="yes">CLCN1</italic> deletions or duplications. Examples of methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="myotonia-c.TF.1.4">
                <label>4. </label>
                <p>A single study of 60 preselected patients revealed larger deletions/duplications in four [<xref ref-type="bibr" rid="myotonia-c.REF.raja_rayan.2012.1953">Raja Rayan et al 2012</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="myotonia-c.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="myotonia-c.Clinical_Description">
          <title>Clinical Description</title>
          <p><bold>The age of onset</bold> is variable. In autosomal dominant myotonia congenita, onset of symptoms is usually in infancy or early childhood. In autosomal recessive myotonia congenita, the average age of onset is slightly older. In both conditions, onset may be as late as the third or fourth decade of life.</p>
          <p><bold>Muscle stiffness.</bold> Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, facial muscles, and tongue may be involved.</p>
          <list list-type="bullet">
            <list-item>
              <p>The physician may note that the individual cannot extend the fingers after shaking hands, or a myotonic contraction may be elicited by percussion of muscles (e.g., the tongue, finger extensors, or thenar muscles).</p>
            </list-item>
            <list-item>
              <p>The stiffness can be relieved by repeated contractions of the muscle, a feature known as the &#x0201c;warm-up&#x0201d; phenomenon. Muscles are usually hypertrophic.</p>
            </list-item>
            <list-item>
              <p>The autosomal recessive form is often associated with more severe symptoms than seen in the autosomal dominant form.</p>
            </list-item>
          </list>
          <p><bold>Muscle weakness.</bold> Individuals with the autosomal recessive form may have progressive, minor distal weakness and attacks of transient weakness brought on by movement after rest. Occasionally, proximal weakness or distal myopathy has been reported [<xref ref-type="bibr" rid="myotonia-c.REF.nagamitsu.2000.1697">Nagamitsu et al 2000</xref>].</p>
          <p><bold>Extramuscular manifestations</bold> such as early cataracts, abnormal cardiac conduction, or endocrine dysfunction are absent.</p>
        </sec>
        <sec id="myotonia-c.GenotypePhenotype_Correlation">
          <title>Genotype-Phenotype Correlations</title>
          <p>The phenotypic manifestations of the pathogenic variants in <italic toggle="yes">CLCN1</italic> can be variable even within the same family [<xref ref-type="bibr" rid="myotonia-c.REF.sun.2001.903">Sun et al 2001</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.coldingj_rgensen.2005.19">Colding-J&#x000f8;rgensen 2005</xref>]. Cases of semi-dominant inheritance, in which a homozygote is more severely affected than a heterozygote, have been reported [<xref ref-type="bibr" rid="myotonia-c.REF.kuo.2006.342">Kuo et al 2006</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.lin.2006.1043">Lin et al 2006</xref>].</p>
          <p>Some individuals with the pathogenic variants <xref ref-type="table" rid="myotonia-c.T.clcn1_variants_discussed_in">p.Gly230Glu</xref> and <xref ref-type="table" rid="myotonia-c.T.clcn1_variants_discussed_in">p.Thr310Met</xref> have been reported to experience a fluctuating phenotype triggered by pregnancy [<xref ref-type="bibr" rid="myotonia-c.REF.lacomis.1999.133">Lacomis et al 1999</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.wu.2002.2392">Wu et al 2002</xref>] and some with the <xref ref-type="table" rid="myotonia-c.T.clcn1_variants_discussed_in">p.Phe428Ser</xref> pathogenic variant have been reported as having a phenotype reminiscent of paramyotonia congenita [<xref ref-type="bibr" rid="myotonia-c.REF.wu.2002.2392">Wu et al 2002</xref>].</p>
          <p>Occasionally, proximal weakness (in individuals with the <xref ref-type="table" rid="myotonia-c.T.clcn1_variants_discussed_in">p.Thr550Met</xref> pathogenic variant) or distal myopathy (in individuals with the <xref ref-type="table" rid="myotonia-c.T.clcn1_variants_discussed_in">p.Pro932Leu</xref> pathogenic variant) has been reported [<xref ref-type="bibr" rid="myotonia-c.REF.nagamitsu.2000.1697">Nagamitsu et al 2000</xref>]. However, the association of these features with <italic toggle="yes">CLCN1</italic> pathogenic variants has been challenged [<xref ref-type="bibr" rid="myotonia-c.REF.simpson.2004.185">Simpson et al 2004</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.coldingj_rgensen.2005.19">Colding-J&#x000f8;rgensen 2005</xref>].</p>
        </sec>
        <sec id="myotonia-c.Penetrance">
          <title>Penetrance</title>
          <p>The majority of the autosomal dominant pathogenic variants can be associated with reduced penetrance. Family members heterozygous for the same pathogenic variant may exhibit variable phenotypes ranging from absence of myotonia to severe myotonia.</p>
        </sec>
        <sec id="myotonia-c.Nomenclature">
          <title>Nomenclature</title>
          <p>Autosomal dominant myotonia congenita is also known as Thomsen disease.</p>
          <p>Autosomal recessive myotonia congenita is also known as Becker disease.</p>
          <p>Myotonia levior is essentially the same as myotonia congenita.</p>
        </sec>
        <sec id="myotonia-c.Prevalence">
          <title>Prevalence</title>
          <p>Myotonia congenita was originally estimated to occur with a frequency of 1:23,000 for autosomal dominant myotonia congenita and 1:50,000 for the autosomal recessive form [<xref ref-type="bibr" rid="myotonia-c.REF.becker.1977">Becker 1977</xref>]. Subsequent studies have suggested that the autosomal recessive form is more common than the autosomal dominant form. In a large cohort of more than 300 affected individuals from the UK, autosomal dominant pathogenic variants were found in only 37% of individuals in whom a pathogenic variant was identified [<xref ref-type="bibr" rid="myotonia-c.REF.fialho.2007.3265">Fialho et al 2007</xref>].</p>
          <p>In northern Scandinavia, the prevalence of myotonia congenita has been estimated at 1:10,000 [<xref ref-type="bibr" rid="myotonia-c.REF.papponen.1999.297">Papponen et al 1999</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.sun.2001.903">Sun et al 2001</xref>], whereas the worldwide prevalence has been estimated at 1:100,000 [<xref ref-type="bibr" rid="myotonia-c.REF.emery.1991.19">Emery 1991</xref>].</p>
        </sec>
      </sec>
      <sec id="myotonia-c.Genetically_Related_Allelic_D">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>A single <italic toggle="yes">CLCN1</italic> pathogenic variant, <xref ref-type="table" rid="myotonia-c.T.clcn1_variants_discussed_in">p.Phe428Ser</xref>, has been associated with a paramyotonia-like phenotype in one individual [<xref ref-type="bibr" rid="myotonia-c.REF.weiss.1997.195">Weiss &#x00026; Mayer 1997</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.wu.2002.2392">Wu et al 2002</xref>]. This finding is unique and should be interpreted with caution [<xref ref-type="bibr" rid="myotonia-c.REF.coldingj_rgensen.2005.19">Colding-J&#x000f8;rgensen 2005</xref>]. Paramyotonia congenita usually results from mutation of <italic toggle="yes">SCN4A</italic>.</p>
        <p>Another variant, p.Arg976Ter, has been associated with epilepsy in a single individual. The variant was shown to be a result of a <italic toggle="yes">de novo</italic> event in the patient, which apart from generalized pharmacoresistant epilepsy also demonstrated mild myotonic features on specific assessment. Further evidence is needed to substantiate the possible relationship between <italic toggle="yes">CLCN1</italic> variants and epilepsy [<xref ref-type="bibr" rid="myotonia-c.REF.chen.2013.1078">Chen et al 2013</xref>].</p>
        <p>Pathogenic variants in <italic toggle="yes">CLCN1</italic> have been identified in patients with confirmed <related-object link-type="booklink" source-id="gene" document-id="myotonic-d2" document-type="chapter">myotonic dystrophy type 2</related-object> (DM2) or sodium channel myotonia. This coexistence may modulate the phenotype and, for DM2, exaggerate the clinical symptoms [<xref ref-type="bibr" rid="myotonia-c.REF.cardani.2012.2090">Cardani et al 2012</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.furby.2014.953">Furby et al 2014</xref>].</p>
      </sec>
      <sec id="myotonia-c.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of myotonia congenita includes other disorders in which myotonia is a prominent finding. Myotonia congenita can usually be distinguished from these disorders based on the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Factors that provoke or alleviate myotonia</p>
          </list-item>
          <list-item>
            <p>Presence or absence of extramuscular manifestations</p>
          </list-item>
          <list-item>
            <p>Findings on electrodiagnostic testing</p>
          </list-item>
        </list>
        <p>
          <bold>Diseases to consider in the differential diagnosis</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Paramyotonia congenita</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/168300">OMIM</ext-link>) (caused by <italic toggle="yes">SCN4A</italic> pathogenic variants) may sometimes be difficult to distinguish from myotonia congenita:</p>
            <list list-type="bullet">
              <list-item>
                <p>Both conditions present with episodes of generalized stiffness in early childhood. Individuals with paramyotonia congenita display extreme cold sensitivity with cold-induced severe stiffness usually followed by true weakness, features not seen in myotonia congenita; however, individuals with myotonia congenita may report some aggravation of stiffness in the cold.</p>
              </list-item>
              <list-item>
                <p>Individuals with myotonia congenita display a pronounced warm-up phenomenon, in which myotonia is relieved with repeated muscle contractions. Conversely, in paramyotonia congenita, repeated muscle contractions may aggravate stiffness (also termed paradoxical myotonia).</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p><bold>Potassium-aggravated myotonia</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/608390">OMIM</ext-link>) (caused by <italic toggle="yes">SCN4A</italic> pathogenic variants) is a diverse group of rare sodium channel disorders. Up to 20% of persons suspected of having myotonia congenita may in fact have pathogenic variants in <italic toggle="yes">SCN4A</italic> [<xref ref-type="bibr" rid="myotonia-c.REF.trip.2008.921">Trip et al 2008</xref>]. In some cases, the myotonia may be associated with episodes of hyperkalemic periodic paralysis (see <related-object link-type="booklink" source-id="gene" document-id="hyper-pp" document-type="chapter">Hyperkalemic Periodic Paralysis Type 1</related-object>). However, if episodes of periodic paralysis are absent, sodium channel (potassium-aggravated) myotonia may be difficult to distinguish from chloride channel myotonia (myotonia congenita) on clinical grounds alone.</p>
            <p>The following clues are helpful [<xref ref-type="bibr" rid="myotonia-c.REF.shapiro.2002">Shapiro &#x00026; Ruff 2002</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.tan.2011">Tan et al 2011</xref>]:</p>
            <list list-type="bullet">
              <list-item>
                <p>Characteristically, symptoms of sodium channel disorders worsen with potassium ingestion, an aggravation that is not seen in myotonia congenita.</p>
              </list-item>
              <list-item>
                <p>Some individuals with sodium channel myotonia have exercise-induced, delayed-onset myotonia, in which muscle contractions induce myotonia after a period of delay. This phenomenon contrasts with the warm-up phenomenon seen in myotonia congenita.</p>
              </list-item>
              <list-item>
                <p>Eye closure myotonia is more frequent in sodium channel myotonia, whereas falls are more frequent in chloride channel myotonia [<xref ref-type="bibr" rid="myotonia-c.REF.tan.2011">Tan et al 2011</xref>].</p>
              </list-item>
              <list-item>
                <p>Many individuals with sodium channel myotonia have painful myotonia, whereas pain is uncommon in chloride channel myotonia.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="myotonic-d" document-type="chapter"><bold>Myotonic dystrophy type 1</bold></related-object>
<bold>(DM1)</bold> and <related-object link-type="booklink" source-id="gene" document-id="myotonic-d2" document-type="chapter"><bold>myotonic dystrophy type 2</bold></related-object>
<bold>(DM2)</bold> should always be considered in the differential diagnosis of myotonia congenita, as the extramuscular manifestations of DM1 and DM2 have important implications for prognosis and management. Although some degree of muscular weakness and wasting may be observed in autosomal recessive myotonia congenita, the pattern of muscle weakness is very different and extramuscular manifestations including early cataracts, abnormal cardiac conduction, or endocrine dysfunction found in DM1 and DM2 are not observed in myotonia congenita. However, the lack of these extramuscular features does not rule out, for example, a mild form of myotonic dystrophy type I.</p>
            <p>DM1 is caused by expansion of a CTG trinucleotide repeat in <italic toggle="yes">DMPK1</italic>; DM2 is caused by a CCTG repeat expansion in intron 1 of <italic toggle="yes">CNBP</italic>, the gene encoding cellular nucleic acid binding protein (zinc finger protein 9) [<xref ref-type="bibr" rid="myotonia-c.REF.liquori.2001.864">Liquori et al 2001</xref>]. Inheritance of DM1 and DM2 is autosomal dominant.</p>
          </list-item>
        </list>
      </sec>
      <sec id="myotonia-c.Management">
        <title>Management</title>
        <sec id="myotonia-c.Evaluations_Following_Initial">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with myotonia congenita, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
            <list-item>
              <p>Consultation with a neurologist or other relevant specialist to evaluate the need for pharmacologic treatment</p>
            </list-item>
          </list>
        </sec>
        <sec id="myotonia-c.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Some individuals with minor complaints may only need to accommodate their activities and lifestyles to reduce symptoms [<xref ref-type="bibr" rid="myotonia-c.REF.shapiro.2002">Shapiro &#x00026; Ruff 2002</xref>]. Myotonic stiffness may respond to sodium channel blockers or other pharmacologic treatment options:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Mexiletine</bold>, a lidocaine derivative, is the best documented treatment option. In a double-blind randomized trial, mexiletine (200 mg 3x/day) significantly reduced stiffness in a group of 59 patients with myotonia, 34 of whom had myotonia congenita [<xref ref-type="bibr" rid="myotonia-c.REF.statland.2012.1357">Statland et al 2012</xref>]. In clinical practice, doses generally begin at 150 mg twice a day, increasing slowly as needed up to 200-300 mg three times a day. The most common potential side effects, including epigastric discomfort, nausea, lightheadedness, dizziness, tremor, and ataxia, are reversible with dose reduction.</p>
            </list-item>
            <list-item>
              <p>Other sodium channel blockers such as <bold>phenytoin</bold> and <bold>carbamazepine</bold> have been reported to have beneficial effects [<xref ref-type="bibr" rid="myotonia-c.REF.conravey.2010.16">Conravey &#x00026; Santana-Gould 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Compounds with other presumed modes of action such as <bold>quinine</bold>, <bold>dantrolene</bold>, or <bold>acetazolamide</bold> may be beneficial in some cases [<xref ref-type="bibr" rid="myotonia-c.REF.shapiro.2002">Shapiro &#x00026; Ruff 2002</xref>].</p>
            </list-item>
          </list>
          <p>See review in <xref ref-type="bibr" rid="myotonia-c.REF.conravey.2010.16">Conravey &#x00026; Santana-Gould [2010]</xref> for a detailed description of these treatment options.</p>
        </sec>
        <sec id="myotonia-c.Prevention_of_Primary_Manifes">
          <title>Prevention of Primary Manifestations</title>
          <p>Exercise temporarily alleviates myotonia (the warm-up effect). A long-term beneficial effect of gymnastics is sometimes reported by affected individuals; the effect has not been systematically studied.</p>
        </sec>
        <sec id="myotonia-c.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>In general, anesthesia should be used with caution [<xref ref-type="bibr" rid="myotonia-c.REF.bandschapp.2013.824">Bandschapp &#x00026; Laizzo 2013</xref>]. Particular care must be taken with the use of <bold>depolarizing muscle relaxants</bold> during anesthesia because they may cause adverse anesthesia-related events. Because life-threatening muscle spasms and secondary ventilation difficulties occurred following a preoperative injection of <bold>suxamethonium</bold>, <xref ref-type="bibr" rid="myotonia-c.REF.farbu.2003.630">Farbu et al [2003]</xref> recommended that suxamethonium be avoided in individuals with myotonia congenita.</p>
          <p>Note: Non-depolarizing muscle relaxants appear to act normally in individuals with myotonia congenita but do not counteract a myotonic response caused by suxamethonium [<xref ref-type="bibr" rid="myotonia-c.REF.farbu.2003.630">Farbu et al 2003</xref>].</p>
          <p>In rare cases, injections of <bold>adrenaline</bold> or <bold>selective beta-adrenergic agonists</bold> in high doses may aggravate myotonia.</p>
          <p>The beta-antagonist <bold>propranolol</bold> has likewise been reported to worsen myotonia [<xref ref-type="bibr" rid="myotonia-c.REF.blessing.1977.73">Blessing &#x00026; Walsh 1977</xref>]. Accordingly, beta-agonists and beta-antagonists should be used with caution and particular care should be taken with the use of intravenous <bold>fenoterol</bold> or <bold>ritodrine</bold>.</p>
          <p><bold>Colchicine</bold> may cause a myopathy with myotonia in individuals with renal insufficiency [<xref ref-type="bibr" rid="myotonia-c.REF.rutkove.1996.870">Rutkove et al 1996</xref>] and may thus also, in theory, aggravate the myotonia of individuals with myotonia congenita.</p>
        </sec>
        <sec id="myotonia-c.Evaluation_of_Relatives_at_Ri">
          <title>Evaluation of Relatives at Risk</title>
          <p>Because individuals with myotonia congenita may be at increased risk for adverse anesthesia-related events, testing of at-risk individuals during childhood to clarify their genetic status is appropriate.</p>
          <list list-type="bullet">
            <list-item>
              <p>If the pathogenic variant(s) in the family are known, molecular genetic testing can be used to clarify the genetic status of at-risk relatives.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant(s) in the family are not known, electromyography can be used to clarify the disease status of at-risk relatives.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="myotonia-c.Related_Genetic_Counseling_Is">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="myotonia-c.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>For an affected mother, a comprehensive birth plan is recommended [<xref ref-type="bibr" rid="myotonia-c.REF.gorthi.2013.293">Gorthi et al 2013</xref>] to minimize the risks of muscular spasms due to factors such as medications, intramuscular injections, and cold.</p>
        </sec>
        <sec id="myotonia-c.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>A trial with <bold>lamotrigine</bold> is ongoing (NCT01939561).</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="myotonia-c.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="myotonia-c.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Myotonia congenita can be inherited in either an autosomal recessive (Becker disease) or an autosomal dominant manner (Thomsen disease). A clear distinction can be difficult because the same pathogenic variant may occur in families with autosomal recessive inheritance and families with autosomal dominant inheritance.</p>
        </sec>
        <sec id="myotonia-c.Risk_to_Family_Members__Autos">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The majority of individuals diagnosed with autosomal dominant myotonia congenita have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with autosomal dominant myotonia congenita may potentially have the disorder as the result of a <italic toggle="yes">de novo</italic>
<italic toggle="yes">CLCN1</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is unknown but presumably very low.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">CLCN1</italic> pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparently <italic toggle="yes">de novo</italic> pathogenic variant include electromyography. Alternatively, a methodology developed to detect low-level mosaicism, such as an NGS-based deep sequencing approach, can potentially uncover a low mosaic state in one of the parents.</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with autosomal dominant myotonia congenita may appear to be negative because of failure to recognize the disorder in family members, reduced penetrance, or early death of the parent before the onset of symptoms. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations (e.g., molecular genetic testing and electromyography) have been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low. However, the sibs of a proband with clinically unaffected parents are still at increased risk for autosomal dominant myotonia congenita because of the possibility of reduced penetrance in a parent.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">CLCN1</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with autosomal dominant myotonia congenita has a 50% chance of inheriting the <italic toggle="yes">CLCN1</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents. If a parent is affected and/or has a <italic toggle="yes">CLCN1</italic> pathogenic variant, his or her family members are at risk.</p>
        </sec>
        <sec id="myotonia-c.Risk_to_Family_Members__Autos_1">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an individual with autosomal recessive myotonia congenita are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">CLCN1</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic. Occasionally, the parents of a proband with autosomal recessive myotonia congenita (the proband has two <italic toggle="yes">CLCN1</italic> pathogenic variants) can show subtle evidence of myotonia on EMG testing. However, they are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are mostly asymptomatic. Occasionally, on thorough clinical evaluation, heterozygotes can show subtle evidence of myotonia on EMG testing. However, they are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with autosomal recessive myotonia congenita are obligate heterozygotes (carriers of a <italic toggle="yes">CLCN1</italic> pathogenic variant).</p>
          <p><bold>Other family members.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of a <italic toggle="yes">CLCN1</italic> pathogenic variant.</p>
        </sec>
        <sec id="myotonia-c.Carrier_Heterozygote_Detectio">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">CLCN1</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="myotonia-c.Related_Genetic_Counseling_Is">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="myotonia-c.Evaluation_of_Relatives_at_Ri">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives.</p>
          <p><bold>Establishing the mode of inheritance in a simplex case</bold> (i.e., the occurrence of a single individual with myotonia congenita in a family) may not be possible unless molecular genetic testing reveals two <italic toggle="yes">CLCN1</italic> pathogenic variants <italic toggle="yes">in trans</italic>, demonstrating autosomal recessive inheritance. Confirmation of phase by segregation analysis is important, as a single allele with two pathogenic variants has been described [<xref ref-type="bibr" rid="myotonia-c.REF.brugnoni.2013.581">Brugnoni et al 2013</xref>]. It should be noted that cases of semi-dominant inheritance, in which a homozygote is more severely affected than a heterozygote, have been reported [<xref ref-type="bibr" rid="myotonia-c.REF.kuo.2006.342">Kuo et al 2006</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.lin.2006.1043">Lin et al 2006</xref>].</p>
          <p><bold>Testing of at-risk asymptomatic relatives</bold> of individuals with myotonia congenita is possible after molecular genetic testing has identified the specific pathogenic variant(s) in the family. Such testing should be performed in the context of formal genetic counseling. This testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing. Because individuals with myotonia congenita may be at risk for adverse anesthesia-related events, testing of at-risk individuals during childhood is appropriate.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="myotonia-c.Prenatal_Testing_and_Preimpla">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">CLCN1</italic> pathogenic variant(s) have been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for myotonia congenita are possible options.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="myotonia-c.Resources">
        <title>Resources</title>
      </sec>
      <sec id="myotonia-c.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="myotonia-c.Molecular_Genetic_Pathogenesi">
          <title>Molecular Genetic Pathogenesis</title>
          <p><italic toggle="yes">CLCN1</italic> encodes the voltage-gated chloride channel ClC-1 (chloride channel protein 1), which is primarily expressed in the sarcolemma, where its main function is to regulate excitability and to stabilize the resting potential. The channel functions as a homodimer, and autosomal recessive myotonia congenita is believed to result from two mutated alleles that reduce functionality, whereas autosomal dominant myotonia congenita is believed to result from a dominant-negative pathogenic variant 'poisoning' the channel. The latter variants are therefore mainly located in the dimer interface, whereas variants associated with recessive MC can be located throughout the protein [<xref ref-type="bibr" rid="myotonia-c.REF.sk_lov_.2013.e82549">Sk&#x000e1;lov&#x000e1; et al 2013</xref>].</p>
          <p>Normally, the chloride conductance contributes 85% to the resting membrane conductance of human muscle, ensuring its electrical stability. The chloride conductance is crucial for countering the depolarizing effect of potassium (K<sup>+</sup>) accumulation in T tubules. If the chloride conductance is reduced to 40% or less, K<sup>+</sup> accumulation in the T-tubular lumen depolarizes the surface membrane sufficiently to initiate self-sustaining action potentials causing a prolonged (myotonic) contraction [<xref ref-type="bibr" rid="myotonia-c.REF.barchi.2001">Barchi 2001</xref>]. A reduction of chloride conductance to 50% apparently does not cause myotonia, because heterozygous carriers of non-functional (&#x02018;autosomal recessive&#x02019;) pathogenic variants are usually asymptomatic.</p>
          <p>On a research basis, the functional consequences of a number of <italic toggle="yes">CLCN1</italic> pathogenic variants have been investigated by expression of the corresponding mutated cDNA sequences in <italic toggle="yes">Xenopus</italic> oocytes or mammalian cells followed by whole-cell patch-clamp recordings.</p>
          <p>The myotonic phenotypes of <related-object link-type="booklink" source-id="gene" document-id="myotonic-d" document-type="chapter">myotonic dystrophy type 1</related-object> and <related-object link-type="booklink" source-id="gene" document-id="myotonic-d2" document-type="chapter">type 2</related-object> are believed to result from missplicing of <italic toggle="yes">CLCN1</italic> mRNA due to an RNA toxic effect of the pathogenic expansion of a CTG repeat in <italic toggle="yes">DMPK</italic> (DM1) and a CCTG repeat in <italic toggle="yes">CNBP</italic> (DM2) [<xref ref-type="bibr" rid="myotonia-c.REF.charletb.2002.45">Charlet-B et al 2002</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.mankodi.2002.35">Mankodi et al 2002</xref>]. A similar effect has recently been proposed for <related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object> (HD), where a CAG expansion in <italic toggle="yes">HTT</italic> in a mouse model impairs <italic toggle="yes">CLCN1</italic> function which in turn could contribute to the chorea, dystonia, and stiffness seen in HD [<xref ref-type="bibr" rid="myotonia-c.REF.waters.2013.9160">Waters et al 2013</xref>].</p>
          <p>The majority of the more than 275 different <italic toggle="yes">CLCN1</italic> pathogenic variants identified to date are associated with autosomal recessive myotonia congenita. Approximately 20 pathogenic variants have solely been associated with autosomal dominant myotonia congenita, whereas approximately 12 pathogenic variants associate with both autosomal recessive and autosomal dominant myotonia congenita, making it difficult to predict mode of inheritance.</p>
          <p>Unambiguous autosomal recessive and autosomal dominant pedigrees have been described only for <xref ref-type="table" rid="myotonia-c.T.clcn1_variants_discussed_in">p.Gly230Glu</xref>, <xref ref-type="table" rid="myotonia-c.T.clcn1_variants_discussed_in">p.Thr310Met</xref>, <xref ref-type="table" rid="myotonia-c.T.clcn1_variants_discussed_in">p.Ala531Val</xref>, and <xref ref-type="table" rid="myotonia-c.T.clcn1_variants_discussed_in">p.Arg894Ter</xref>. This peculiar phenomenon may be explained by the following [<xref ref-type="bibr" rid="myotonia-c.REF.koty.1996.963">Koty et al 1996</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.mail_nder.1996.317">Mail&#x000e4;nder et al 1996</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.zhang.1996.993">Zhang et al 1996</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.plassartschiess.1998.1176">Plassart-Schiess et al 1998</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.dun_.2004.738">Dun&#x000f8; et al 2004</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.bernard.2008.163">Bernard et al 2008</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.richardson.2014.593">Richardson et al 2014</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Reduced penetrance of dominant-negative pathogenic variants</p>
            </list-item>
            <list-item>
              <p>Incomplete dominance</p>
            </list-item>
            <list-item>
              <p>Haplotype background</p>
            </list-item>
            <list-item>
              <p>Incomplete pathogenic variant detection</p>
            </list-item>
            <list-item>
              <p>Differences in allelic expression</p>
            </list-item>
          </list>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">CLCN1</italic> spans 36 kb and contains 23 exons with a transcript length of 3093 nucleotides. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="myotonia-c" object-id="myotonia-c.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold> More than 275 different pathogenic variants have been identified, the majority of which are associated with autosomal recessive myotonia congenita. Pathogenic variants (both recessive and dominant) appear to be scattered throughout the coding sequence and are mostly missense or nonsense variants (<xref ref-type="table" rid="myotonia-c.T.clcn1_variants_discussed_in">Table 2</xref>). Pathogenic variants causing dominant myotonia congenita are often located in exon 8 [<xref ref-type="bibr" rid="myotonia-c.REF.fialho.2007.3265">Fialho et al 2007</xref>].</p>
          <p>The p.Arg894Ter pathogenic variant is probably the most common semi-dominant pathogenic variant with homozygotes being more severely affected than heterozygotes [<xref ref-type="bibr" rid="myotonia-c.REF.kuo.2006.342">Kuo et al 2006</xref>, <xref ref-type="bibr" rid="myotonia-c.REF.lin.2006.1043">Lin et al 2006</xref>].</p>
          <table-wrap id="myotonia-c.T.clcn1_variants_discussed_in" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p><italic toggle="yes">CLCN1</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.689G&#x0003e;A</td>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly230Glu</td>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_3" rowspan="8" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=119433676">NM_000083.2</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=119433677">NP_000074.2</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.929C&#x0003e;T</td>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">pThr310Met</td>
                </tr>
                <tr>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1283T&#x0003e;C</td>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe428Ser</td>
                </tr>
                <tr>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1592C&#x0003e;T</td>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala531Val</td>
                </tr>
                <tr>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1649C&#x0003e;T</td>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr550Met</td>
                </tr>
                <tr>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2680C&#x0003e;T</td>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg894Ter</td>
                </tr>
                <tr>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2795C&#x0003e;T</td>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro932Leu</td>
                </tr>
                <tr>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2926C&#x0003e;T</td>
                  <td headers="hd_h_myotonia-c.T.clcn1_variants_discussed_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg976Ter</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">CLCN1</italic> encodes the protein ClC-1, which consists of 988 amino acids and contains numerous transmembrane domains. The functional ClC-1 channel contributes approximately 80% of the total resting conductance and determines membrane excitability.</p>
          <p><bold>Abnormal gene product.</bold> Recessive pathogenic variants are presumed to cause loss of function of the channel; dominant pathogenic variants presumably act through a dominant-negative mechanism, by primarily affecting dimerization [<xref ref-type="bibr" rid="myotonia-c.REF.sk_lov_.2013.e82549">Sk&#x000e1;lov&#x000e1; et al 2013</xref>].</p>
        </sec>
      </sec>
      <sec id="myotonia-c.References">
        <title>References</title>
        <sec id="myotonia-c.Published_GuidelinesConsensus">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="myotonia-c.Published_GuidelinesConsensus.reflist0">
            <ref id="myotonia-c.REF.tan.2011">
              <mixed-citation publication-type="web">Tan SV, Matthews E, Barber M, Burge JA, Rajakulendran S, Fialho D, Sud R, Haworth A, Koltzenburg M, Hanna MG. Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://onlinelibrary.wiley.com/doi/10.1002/ana.22238/pdf">online</ext-link>. 2011. Accessed 1-19-17</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="myotonia-c.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="myotonia-c.Literature_Cited.reflist0">
            <ref id="myotonia-c.REF.bandschapp.2013.824">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bandschapp</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laizzo</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Pathophysiologic and anesthetic considerations for patients with myotonia congenita or periodic paralyses.</article-title>
                <source>Paediatr Anaesth</source>
                <volume>23</volume>
                <fpage>824</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">23802937</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.barchi.2001">
              <mixed-citation publication-type="book">Barchi R. The pathophysiology of excitation in skeletal muscle. In: Karpati G, Hilton-Jones D, Griggs RC, eds. <italic toggle="yes">Disorders of Voluntary Muscle</italic>. 7 ed. Cambridge, UK: Cambridge University Press. 2001:168-86.</mixed-citation>
            </ref>
            <ref id="myotonia-c.REF.becker.1977">
              <mixed-citation publication-type="book">Becker PE. <italic toggle="yes">Myotonia Congenita and Syndromes Associated with Myotonia. Topics in Human Genetics</italic>. Stuttgart, Germany: Georg Thieme. 1977.</mixed-citation>
            </ref>
            <ref id="myotonia-c.REF.bernard.2008.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puymirat</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sternberg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shevell</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Dosage effect of a dominant CLCN1 mutation: a novel syndrome.</article-title>
                <source>J Child Neurol.</source>
                <volume>23</volume>
                <fpage>163</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18263754</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.blessing.1977.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blessing</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>1977</year>
                <article-title>Myotonia precipitated by propranolol therapy.</article-title>
                <source>Lancet</source>
                <volume>1</volume>
                <fpage>73</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">63714</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.brugnoni.2013.581">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brugnoni</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kapetis</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imbrici</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pessia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canioni</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colleoni</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Rosbo</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morandi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cudia</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gashemi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernasconi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desaphy</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conte</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mantegazza</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>A large cohort of myotonia congenita probands: novel mutations and a high-frequency mutation region in exons 4 and 5 of the CLCN1 gene.</article-title>
                <source>J Hum Genet.</source>
                <volume>58</volume>
                <fpage>581</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23739125</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.cardani.2012.2090">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cardani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giagnacovo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinaldi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgante</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raheem</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penttil&#x000e4;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suominen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renna</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sansone</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bugiardini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Novelli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meola</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2.</article-title>
                <source>J Neurol.</source>
                <volume>259</volume>
                <fpage>2090</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22407275</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.charletb.2002.45">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Charlet-B</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savkur</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philips</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grice</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>TA</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.</article-title>
                <source>Mol Cell</source>
                <volume>10</volume>
                <fpage>45</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">12150906</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.chen.2013.1078">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>TT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klassen</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldman</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noebels</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Novel brain expression of ClC-1 chloride channels and enrichment of CLCN1 variants in epilepsy.</article-title>
                <source>Neurology.</source>
                <volume>80</volume>
                <fpage>1078</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">23408874</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.coldingj_rgensen.2005.19">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Colding-J&#x000f8;rgensen</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Phenotypic variability in myotonia congenita.</article-title>
                <source>Muscle Nerve</source>
                <volume>32</volume>
                <fpage>19</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">15786415</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.conravey.2010.16">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Conravey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santana-Gould</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Myotonia congenita and myotonic dystrophy: surveillance and management.</article-title>
                <source>Curr Treat Options Neurol.</source>
                <volume>12</volume>
                <fpage>16</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">20842486</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.dun_.2004.738">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dun&#x000f8;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colding-J&#x000f8;rgensen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grunnet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jespersen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vissing</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Difference in allelic expression of the CLCN1 gene and the possible influence on the myotonia congenita phenotype.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>12</volume>
                <fpage>738</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">15162127</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.emery.1991.19">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Emery</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Population frequencies of inherited neuromuscular diseases - a world survey.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>1</volume>
                <fpage>19</fpage>
                <lpage>29</lpage>
                <pub-id pub-id-type="pmid">1822774</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.farbu.2003.630">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Farbu</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Softeland</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bindoff</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders.</article-title>
                <source>Acta Anaesthesiol Scand</source>
                <volume>47</volume>
                <fpage>630</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12699527</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.fialho.2007.3265">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fialho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schorge</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pucovska</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labrum</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haworth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanley</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sud</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakeling</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kullmann</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>3265</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">17932099</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.furby.2014.953">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Furby</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vicart</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camdessanch&#x000e9;</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fournier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagrue</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paricio</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blondy</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touraine</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sternberg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Heterozygous CLCN1 mutations can modulate phenotype in sodium channel myotonia.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2014</year>
                <volume>24</volume>
                <fpage>953</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">25088311</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.gorthi.2013.293">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gorthi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radbourne</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drury</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajagopalan</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Management of pregnancy with Thomsen's disease.</article-title>
                <source>Eur J Obstet Gynecol Reprod Biol.</source>
                <volume>170</volume>
                <fpage>293</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">23806446</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.koty.1996.963">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koty</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pegoraro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hobson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marks</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flagler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cadaldini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>EP</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect.</article-title>
                <source>Neurology</source>
                <volume>47</volume>
                <fpage>963</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8857727</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.kuo.2006.342">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kuo</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsiao</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>LI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>You</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yeh</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>CC</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Novel mutations at carboxyl terminus of CIC-1 channel in myotonia congenita.</article-title>
                <source>Acta Neurol Scand</source>
                <volume>113</volume>
                <fpage>342</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16629771</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.lacomis.1999.133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lacomis</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzales</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giuliani</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Fluctuating clinical myotonia and weakness from Thomsen's disease occurring only during pregnancies.</article-title>
                <source>Clin Neurol Neurosurg</source>
                <volume>101</volume>
                <fpage>133</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10467912</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.lin.2006.1043">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>You</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsiao</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Functional characterization of CLCN1 mutations in Taiwanese patients with myotonia congenita via heterologous expression.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>351</volume>
                <fpage>1043</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17097617</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.liquori.2001.864">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liquori</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ricker</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moseley</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobsen</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naylor</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Day</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ranum</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.</article-title>
                <source>Science</source>
                <volume>293</volume>
                <fpage>864</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11486088</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.mail_nder.1996.317">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mail&#x000e4;nder</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heine</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deymeer</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann-Horn</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Novel muscle chloride channel mutations and their effects on heterozygous carriers.</article-title>
                <source>Am J Hum Genet</source>
                <volume>58</volume>
                <fpage>317</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">8571958</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.mankodi.2002.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mankodi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beck</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowers</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moxley</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannon</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thornton</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy.</article-title>
                <source>Mol Cell</source>
                <volume>10</volume>
                <fpage>35</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">12150905</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.nagamitsu.2000.1697">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nagamitsu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khajavi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gooch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harati</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashizawa</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>A "dystrophic" variant of autosomal recessive myotonia congenita caused by novel mutations in the CLCN1 gene.</article-title>
                <source>Neurology</source>
                <volume>55</volume>
                <fpage>1697</fpage>
                <lpage>703</lpage>
                <pub-id pub-id-type="pmid">11113225</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.papponen.1999.297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Papponen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toppinen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myllyla</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leisti</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuivaniemi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tromp</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myllyla</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Founder mutations and the high prevalence of myotonia congenita in northern Finland.</article-title>
                <source>Neurology</source>
                <volume>53</volume>
                <fpage>297</fpage>
                <lpage>302</lpage>
                <pub-id pub-id-type="pmid">10430417</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.plassartschiess.1998.1176">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Plassart-Schiess</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gervais</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagueny</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouget</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warter</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Novel muscle chloride channel (CLCN1) mutations in myotonia congenita with various modes of inheritance including incomplete dominance and penetrance.</article-title>
                <source>Neurology</source>
                <volume>50</volume>
                <fpage>1176</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9566422</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.raja_rayan.2012.1953">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raja Rayan</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haworth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sud</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fialho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Portaro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schorge</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuin</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lunt</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McEntagart</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toscano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>A new explanation for recessive myotonia congenita: exon deletions and duplications in CLCN1.</article-title>
                <source>Neurology.</source>
                <volume>78</volume>
                <fpage>1953</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22649220</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.richardson.2014.593">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richardson</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tarleton</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gospe</surname>
                    <given-names>SM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Truncating CLCN1 mutations in myotonia congenita: variable patterns of inheritance.</article-title>
                <source>Muscle Nerve.</source>
                <volume>49</volume>
                <fpage>593</fpage>
                <lpage>600</lpage>
                <pub-id pub-id-type="pmid">23893571</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.rutkove.1996.870">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rutkove</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeGirolami</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Preston</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardin</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gouras</surname>
                    <given-names>GK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johns</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raynor</surname>
                    <given-names>EM</given-names>
                  </name>
                </person-group>
                <article-title>Myotonia in colchicine myoneuropathy.</article-title>
                <source>Muscle Nerve.</source>
                <year>1996</year>
                <volume>19</volume>
                <fpage>870</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">8965841</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.shapiro.2002">
              <mixed-citation publication-type="book">Shapiro B, Ruff R. Disorders of skeletal muscle membrane excitability: myotonia congenita, paramyotonia congenita, periodic paralysis, and related disorders. In: Katirji B, Kaminski H, Preston D, Ruff R, Shapiro B, eds. <italic toggle="yes">Neuromuscular Disorders in Clinical Practice</italic>. Philadelphia, PA: Butterworth-Heinemann; 2002:987-1020.</mixed-citation>
            </ref>
            <ref id="myotonia-c.REF.simpson.2004.185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Simpson</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Height</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rychkov</surname>
                    <given-names>GY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nowak</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laing</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>BP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bretag</surname>
                    <given-names>AH</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Characterization of three myotonia-associated mutations of the CLCN1 chloride channel gene via heterologous expression.</article-title>
                <source>Hum Mutat</source>
                <volume>24</volume>
                <fpage>185</fpage>
                <pub-id pub-id-type="pmid">15241802</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.sk_lov_.2013.e82549">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sk&#x000e1;lov&#x000e1;</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000ed;dkov&#x000e1;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voh&#x000e1;&#x00148;ka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazanec</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mu&#x00161;ov&#x000e1;</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vondr&#x000e1;&#x0010d;ek</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mr&#x000e1;zov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000e9;blov&#x000e1;</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fajkusov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>CLCN1 mutations in Czech patients with myotonia congenita, in silico analysis of novel and known mutations in the human dimeric skeletal muscle chloride channel.</article-title>
                <source>PLoS One.</source>
                <volume>8</volume>
                <fpage>e82549</fpage>
                <pub-id pub-id-type="pmid">24349310</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.statland.2012.1357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Statland</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bundy</surname>
                    <given-names>BN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rayan</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trivedi</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sansone</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salajegheh</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venance</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciafaloni</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meola</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herbelin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griggs</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barohn</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Consortium for Clinical Investigation of Neurologic Channelopathies. Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial.</article-title>
                <source>JAMA</source>
                <volume>308</volume>
                <fpage>1357</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">23032552</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.sun.2001.903">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranebjaerg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torbergsen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmgren</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Ghelue</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>9</volume>
                <fpage>903</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11840191</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.tan.2011.328">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>SV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barber</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burge</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajakulendran</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fialho</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sud</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haworth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koltzenburg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies.</article-title>
                <source>Ann Neurol.</source>
                <volume>69</volume>
                <fpage>328</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">21387378</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.trip.2008.921">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Trip</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drost</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verbove</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Kooi</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuks</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Notermans</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verschuuren</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Visser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Engelen</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faber</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ginjaar</surname>
                    <given-names>IB</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia.</article-title>
                <source>Eur J Hum Genet.</source>
                <volume>16</volume>
                <fpage>921</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18337730</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.waters.2013.9160">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Waters</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varuzhanyan</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talmadge</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voss</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Huntington disease skeletal muscle is hyperexcitable owing to chloride and potassium channel dysfunction.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2013</year>
                <volume>110</volume>
                <fpage>9160</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">23671115</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.weiss.1997.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayer</surname>
                    <given-names>RF</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Temperature-sensitive repetitive discharges in paramyotonia congenita.</article-title>
                <source>Muscle Nerve</source>
                <volume>20</volume>
                <fpage>195</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9040658</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.wu.2002.2392">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>FF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devaney</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warnstedt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korade-Mirnics</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poser</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Escriva</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pegoraro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yee</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Felice</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giuliani</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayer</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mongini</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmucci</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahlke</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Novel CLCN1 mutations with unique clinical and electrophysiological consequences.</article-title>
                <source>Brain</source>
                <volume>125</volume>
                <fpage>2392</fpage>
                <lpage>407</lpage>
                <pub-id pub-id-type="pmid">12390967</pub-id>
              </element-citation>
            </ref>
            <ref id="myotonia-c.REF.zhang.1996.993">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>George</surname>
                    <given-names>AL</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Griggs</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fouad</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwieci&#x00144;ski</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connolly</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pt&#x000e1;cek</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita.</article-title>
                <source>Neurology</source>
                <volume>47</volume>
                <fpage>993</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8857733</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="myotonia-c.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="myotonia-c.Suggested_Reading.reflist0">
            <ref id="myotonia-c.REF.imbrici.2015">
              <mixed-citation publication-type="other">Imbrici P, Altamura C, Pessia M, Mantegazza R, Desaphy JF, Camerino DC (2015) ClC-1 chloride channels: state-of-the-art research and future challenges. Front Cell Neurosci. 27;9:156</mixed-citation>
            </ref>
            <ref id="myotonia-c.REF.jen">
              <mixed-citation publication-type="web">Jen JC, Pt&#x000e1;&#x0010d;ek L. Channelopathies: episodic disorders of the nervous system. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</italic> Chap 204. McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com">online</ext-link>.</mixed-citation>
            </ref>
            <ref id="myotonia-c.REF.jentsch.2005.779">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Po&#x000eb;t</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuhrmann</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zdebik</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Physiological functions of CLC Cl- channels gleaned from human genetic disease and mouse models.</article-title>
                <source>Annu Rev Physiol</source>
                <volume>67</volume>
                <fpage>779</fpage>
                <lpage>807</lpage>
                <pub-id pub-id-type="pmid">15709978</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="myotonia-c.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="myotonia-c.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>6 August 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>12 April 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>8 July 2008 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>3 August 2005 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>14 December 2004 (md) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
